Pluri announces cultivated meat JV with Tnuva reaches proof of concept; CEO takes salary cut for equity

Pluri Inc.

Joint venture with Tnuva Group reached proof of concept in cultivated meat development using Pluri's 3D cell platform.
New biologics partnership with European API manufacturer for liver and gastroenterological disease treatments.
Company reduced cash burn by ~30% and secured $8.4M new investment via securities purchase agreements.
CEO Yaky Yanay foregoes $375,000 cash salary over 12 months in exchange for equity grants.
EU Horizon Europe awarded €7.5M non-dilutive grant for knee osteoarthritis study using PLX-PAD cells.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.